Xusheng Yang
Nanjing Medical University
11 Papers
7 Citations
Xusheng Yang is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: Cancer research & Medicine. The author has an hindex of 2, co-authored 6 publications.
Chat about Author
Papers
Interferon-γ induces retinal pigment epithelial cell Ferroptosis by a JAK1-2/STAT1/SLC7A11 signaling pathway in Age-related Macular Degeneration.
Ting-Ting Wei,Meng-Yuan Zhang,Xin-Hua Zheng,Tianhua Xie,Wenjuan Wang,Jian Zou,Yan Li,Hong-Ying Li,Jiping Cai,Xiaolu Wang,Jianxin Tan,Xusheng Yang,Yong Yao,Lingpeng Zhu +13 more
TL;DR: In this article, an increase of interferon-γ (IFN-γ) levels was observed in patients with AMD, but whether inflammatory factors are causally related to AMD progression is unclear.
67
Periostin: A Potential Therapeutic Target For Pulmonary Hypertension?
Xiao-Wei Nie,Chenyou Shen,Jianxin Tan,Zhi-Yuan Wu,Wei Wang,Yuan Chen,Youai Dai,Xusheng Yang,Shugao Ye,Jingyu Chen,Jin-Song Bian,Jin-Song Bian +11 more
TL;DR: This study reveals that POSTN expression is increased in human and animal models of PH and fosters PH development via a positive feedback loop between HIF-1α and POSTN during hypoxia and proposes that manipulating POSTIN expression may be an efficacious therapeutic target in the treatment of PH.
56
TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling.
Lingpeng Zhu,Wenjuan Wang,Tianhua Xie,Jian Zou,Xiaowei Nie,Xiaolu Wang,Meng-Yuan Zhang,Zhong-Yuan Wang,Shun Gu,Miao Zhuang,Jianxin Tan,Chenyou Shen,Youai Dai,Xusheng Yang,Yong Yao,Ting-Ting Wei +15 more
TL;DR: It is shown that bile acids were downregulated during DR progression in the diabetic rat retinas and RMECs cultured in high glucose medium, suggesting that insufficient BA signaling plays an important pathogenic role in the development of DR.
43
SHF Acts as a Novel Tumor Suppressor in Glioblastoma Multiforme by Disrupting STAT3 Dimerization
Jingjing Wang,Zixuan Huang,Linong Ji,Cheng Chen,Quan Wan,Yu Xin,Zhening Pu,Jiantong Jiao,Ying-Chun Yin,Yaling Hu,Lingli Gong,Rui Zhang,Xusheng Yang,Xiangming Fang,Mei Wang,Junfei Shao,Jian Zou +16 more
TL;DR: Targeting of the SHF/STAT3 interaction is identified as a promising strategy for developing an optimal STAT3 inhibitor and early evidence of the potential clinical efficacy of STAT3 inhibitors such as C16 in GBM is provided.
11
SB203580 protects against inflammatory response and lung injury in a mouse model of lipopolysaccharide‑induced acute lung injury.
Guirong Li,Youai Dai,Jianxin Tan,Jian Zou,Xiaowei Nie,Yang Zhenkun,Jingjing Zhao,Xusheng Yang,Jingyu Chen +8 more
TL;DR: It is demonstrated that SB203580 protected against inflammatory responses and lung injury by inhibiting lung edema and downregulating proinflammatory mediators in LPS‑induced lung injury.